Disc Medicine (IRON) Interest & Investment Income (2020 - 2026)
Disc Medicine's (IRON) quarterly Interest & Investment Income came in at $6.9 million in Q1 2026, little changed year-on-year from $6.9 million in Q1 2025, and down 7.0% on a QoQ basis from $7.4 million in Q4 2025.
Disc Medicine (IRON) Interest & Investment Income (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Interest & Investment Income data on file, last reported at $6.9 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income changed 0.19% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $27.8 million, a 17.42% increase from a year earlier, with the FY2025 full-year figure at $27.8 million, up 30.38% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $6.9 million, down from $7.4 million in the prior quarter.
- Over the last five years, Interest & Investment Income for IRON reached as high as $7.4 million in Q4 2025 and fell as low as $7000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $4.2 million across 5 years, with a median of $4.7 million in 2023.
- Across the five-year window, Interest & Investment Income surged 33714.29% in 2023 and gained 0.19% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $388000.0 in 2022, then soared by 1105.41% to $4.7 million in 2023, then grew by 24.82% to $5.8 million in 2024, then gained by 26.96% to $7.4 million in 2025, then dropped by 7.0% to $6.9 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $6.9 million in Q1 2026, $7.4 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Disc Medicine | 2.89 Bn | 2.89 Bn | - | 6.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 7.41 Mn |
| Sep 30, 2025 | 6.41 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 5.84 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Dec 31, 2023 | 4.68 Mn |
| Sep 30, 2023 | 4.84 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 2.37 Mn |
| Dec 31, 2022 | 388,000.00 |
| Sep 30, 2022 | 269,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |